コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ons compared to cold biopsy forceps (without electrocautery).
2 perceptual ability, and performance of safe electrocautery.
3 h, airway nebulization, open suctioning, and electrocautery.
4 heostomy procedures (n = 4), with or without electrocautery.
5 , TSP at the level of the fossa ovalis using electrocautery and a standard open-ended Brockenbrough n
7 Punctures were performed without the use of electrocautery and by delivering radiofrequency energy t
8 y compares the cure rates of battery-powered electrocautery and curettage vs electrodesiccation and c
10 2, 100 participants were enrolled (36 in the electrocautery arm, 28 in the cidofovir arm, and 36 in t
11 ment of benign prostatic hyperplasia was the electrocautery-based transurethral resection of the pros
12 was observed in 7 participants (28%) in the electrocautery group, 7 (30.4%) in the cidofovir group,
13 terval [CI]: 54.4%-84.5%) of patients in the electrocautery group, 82.1% (95% CI: 67.9%-96.3%) in the
14 ts were reported by 97.2% of patients in the electrocautery group, 85.7% in the cidofovir group, and
15 ction control, including performing laser or electrocautery in ventilated rooms using standard precau
19 s treatment (mean, 5.6 +/- 0.4), followed by electrocautery (mean, 5.1 +/- 0.8), while lower satisfac
20 inum-garnet laser, argon plasma coagulation, electrocautery, nonthermal ablation with alcohol injecti
22 y to the transseptal needle using a standard electrocautery pen at 3 target sites (fossa ovalis, non-
24 becular meshwork (TM) using a high-frequency electrocautery probe tip, promoting aqueous humor outflo
25 airway humidification, open suctioning, and electrocautery produced aerosol particles substantially
27 is traditionally performed using a monopolar electrocautery system resulting in the possibility of ce
31 tal neoplasia is typically carried out using electrocautery tools which imply limited precision and t
32 mly assigned 1:1:1 to receive treatment with electrocautery, topical cidofovir 1% ointment, or topica